Bortezomib regimen improves stem cell transplantation outcomes – Oncology Nurse Advisor
|
Bortezomib regimen improves stem cell transplantation outcomes
Oncology Nurse Advisor Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem cell transplants from mismatched and unrelated donors, according to research presented at the 2013 … |
